NEW YORK (Reuters Health) - A synthetic translation of the "hunger hormone" ghrelin might help limit the loss of craving that can come with cancer chemotherapy, a insignificant study from Japan suggests.

Ghrelin is a hormone secreted ~ means of the gut to boost appetite. Because of that, scientists desire been studying it as a target in the obesity war, which has included be on an anti-obesity "vaccine" that inhibits ghrelin. But the study has met with little success in the way that far.

Since the hormone spurs craving for food, in theory, infusions of synthetic ghrelin could aid prevent the sometimes severe appetite overthrow caused by cancer drugs.

In precise, a commonly used cancer drug called cisplatin ~times causes nausea, vomiting and appetite defeat -- and cuts the body's unregenerate ghrelin levels.

For the new study, Japanese researchers tested the effects of ghrelin infusions in 41 patients undergoing cisplatin treatment for advanced cancer of the gullet.

Half of the patients were randomly assigned to wish ghrelin infusions twice a day, preceding their meals, over one week of chemotherapy. The rest were given infusions of salt-pit.

In the end, the ghrelin patients maintained more familiar appetites and were able to take in toward 50 percent more calories per generation than patients given saline.

Overall, other thing than half of the saline cluster had nausea, versus one in five ghrelin patients. And space of time half of the saline group had anorexia -- momentous appetite loss -- during chemo, only individual in six ghrelin patients did.

Dr. Yuichiro Hiura and colleagues at Osaka University sound their findings in the journal Cancer. The study was funded ~ dint of. a grant from the Japanese guidance.

It appears to be the primitive to show that ghrelin may succor cancer patients being treated with cisplatin, in the same manner further studies are needed, the researchers recite.

There is already a medication -- united that decreases the activity of the hormone serotonin -- that eases repugnance and vomiting in the first 24 hours of cisplatin handling, Hiura's team notes.

But, they ~ together, lingering nausea and appetite loss in the following days are quiet a challenge to control. So ghrelin could pr~ a way to help with those longer-space of time effects.

Intensive chemotherapy with multiple drugs, including cisplatin, is commonly used in the place of advanced-stage cancer, Hiura's team writes. But oblique effects may keep many patients from completing their handling.

Ultimately, the researchers say, the goal is to cause to be chemotherapy easier for patients to cause to be through -- and, it's hoped, improve the manipulation's effectiveness.

SOURCE: http://bit.ly/wB771x Cancer, online January 26, 2012.

@yahoonews in successi~ Twitter, become a fan on Facebook